SG Americas Securities’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,988
| Closed | -$383K | – | 3393 |
|
|
2025
Q2 | $383K | Sell |
2,988
-4,288
| -59% | -$445K | ﹤0.01% | 1839 |
|
|
2025
Q1 | $644K | Buy |
7,276
+2,999
| +70% | +$293K | ﹤0.01% | 1569 |
|
|
2024
Q4 | $373K | Buy |
4,277
+1,756
| +70% | +$161K | ﹤0.01% | 1609 |
|
|
2024
Q3 | $233K | Sell |
2,521
-19,163
| -88% | -$1.9M | ﹤0.01% | 2371 |
|
|
2024
Q2 | $2.34M | Buy |
21,684
+9,819
| +83% | +$983K | 0.01% | 876 |
|
|
2024
Q1 | $1.13M | Buy |
11,865
+6,412
| +118% | +$550K | 0.01% | 1090 |
|
|
2023
Q4 | $503K | Sell |
5,453
-28,025
| -84% | -$1.82M | ﹤0.01% | 1476 |
|
|
2023
Q3 | $1.68M | Buy |
33,478
+31,299
| +1,436% | +$1.67M | 0.02% | 868 |
|
|
2023
Q2 | $138K | Buy |
+2,179
| New | +$118K | ﹤0.01% | 1949 |
|
|
2022
Q4 | – | Sell |
-11,537
| Closed | -$760K | – | 3076 |
|
|
2022
Q3 | $760K | Sell |
11,537
-7,846
| -40% | -$504K | 0.01% | 1200 |
|
|
2022
Q2 | $979K | Buy |
19,383
+1,189
| +7% | +$69.7K | 0.01% | 1315 |
|
|
2022
Q1 | $1.16M | Sell |
18,194
-18,033
| -50% | -$1.29M | 0.01% | 1319 |
|
|
2021
Q4 | $3.88M | Buy |
36,227
+12,052
| +50% | +$1.26M | 0.02% | 615 |
|
|
2021
Q3 | $2.48M | Buy |
24,175
+4,029
| +20% | +$375K | 0.01% | 1077 |
|
|
2021
Q2 | $1.77M | Buy |
20,146
+9,219
| +84% | +$845K | 0.01% | 1197 |
|
|
2021
Q1 | $1.06M | Buy |
10,927
+8,548
| +359% | +$853K | 0.01% | 1494 |
|
|
2020
Q4 | $267K | Sell |
2,379
-21,805
| -90% | -$2.3M | ﹤0.01% | 2452 |
|
|
2020
Q3 | $2.24M | Sell |
24,184
-9,500
| -28% | -$732K | 0.01% | 680 |
|
|
2020
Q2 | $2.63M | Buy |
33,684
+18,548
| +123% | +$1.25M | 0.02% | 663 |
|
|
2020
Q1 | $885K | Sell |
15,136
-731
| -5% | -$47K | 0.01% | 1380 |
|
|
2019
Q4 | $1.27M | Buy |
15,867
+10,658
| +205% | +$798K | 0.01% | 1104 |
|
|
2019
Q3 | $383K | Buy |
5,209
+2,415
| +86% | +$209K | ﹤0.01% | 2025 |
|
|
2019
Q2 | $264K | Sell |
2,794
-5,579
| -67% | -$460K | ﹤0.01% | 2259 |
|
|
2019
Q1 | $670K | Sell |
8,373
-1,589
| -16% | -$117K | 0.01% | 1584 |
|
|
2018
Q4 | $537K | Buy |
9,962
+8,260
| +485% | +$502K | ﹤0.01% | 1821 |
|
|
2018
Q3 | $133K | Sell |
1,702
-1,725
| -50% | -$120K | ﹤0.01% | 2749 |
|
|
2018
Q2 | $218K | Buy |
3,427
+285
| +9% | +$22.7K | ﹤0.01% | 2550 |
|
|
2018
Q1 | $288K | Buy |
+3,142
| New | +$271K | ﹤0.01% | 2205 |
|
|
2017
Q4 | – | Sell |
-8,673
| Closed | -$604K | – | 3212 |
|
|
2017
Q3 | $604K | Buy |
8,673
+4,560
| +111% | +$244K | 0.01% | 1684 |
|
|
2017
Q2 | $208K | Buy |
4,113
+778
| +23% | +$33K | ﹤0.01% | 2399 |
|
|
2017
Q1 | $133K | Sell |
3,335
-7,926
| -70% | -$284K | ﹤0.01% | 2760 |
|
|
2016
Q4 | $316K | Buy |
+11,261
| New | +$339K | ﹤0.01% | 1996 |
|
Other funds holding BPMC
IA
HNB
SG Americas Securities's BPMC Position: Q3 2025 in Review
SG Americas Securities sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,988 shares — an estimated $383K sold.
SG Americas Securities first reported a position in BPMC in Q4 2016 and held it in 32 quarters. The position peaked at $3.88M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- SG Americas Securities reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- SG Americas Securities sold 2,988 Blueprint Medicines shares in Q3 2025, an estimated $383K.
- SG Americas Securities first reported a position in Blueprint Medicines in Q4 2016 and held it in 32 quarters.
- SG Americas Securities's Blueprint Medicines position peaked at $3.88M in Q4 2021.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.